Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases

We have previously published a study on the reliable detection of 2-hydroxyglutarate (2HG) in lower-grade gliomas by magnetic resonance spectroscopy (MRS). In this short article, we re-evaluated five glioma cases originally assessed as isocitrate dehydrogenase (IDH) wildtype, which showed a high acc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manabu Natsumeda, Hironaka Igarashi, Ramil Gabdulkhaev, Haruhiko Takahashi, Kunio Motohashi, Ryosuke Ogura, Jun Watanabe, Yoshihiro Tsukamoto, Kouichirou Okamoto, Akiyoshi Kakita, Tsutomu Nakada, Yukihiko Fujii
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/02c8ce6392cb47eda48b441c0572e5df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:02c8ce6392cb47eda48b441c0572e5df
record_format dspace
spelling oai:doaj.org-article:02c8ce6392cb47eda48b441c0572e5df2021-11-25T17:21:51ZDetection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases10.3390/diagnostics111121292075-4418https://doaj.org/article/02c8ce6392cb47eda48b441c0572e5df2021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2129https://doaj.org/toc/2075-4418We have previously published a study on the reliable detection of 2-hydroxyglutarate (2HG) in lower-grade gliomas by magnetic resonance spectroscopy (MRS). In this short article, we re-evaluated five glioma cases originally assessed as isocitrate dehydrogenase (IDH) wildtype, which showed a high accumulation of 2HG, and were thought to be false-positives. A new primer was used for the detection of <i>IDH2</i> mutation by Sanger sequencing. Adequate tissue for DNA analysis was available in 4 out of 5 cases. We found rare <i>IDH2</i> mutations in two cases, with <i>IDH2</i> R172W mutation in one case and <i>IDH2</i> R172K mutation in another case. Both cases had very small mutant peaks, suggesting that the tumor volume was low in the tumor samples. Thus, the specificity of MRS for detecting IDH1/2 mutations was higher (81.3%) than that originally reported (72.2%). The detection of 2HG by MRS can aid in the diagnosis of rare, non-IDH1-R132H <i>IDH1</i> and <i>IDH2</i> mutations in gliomas.Manabu NatsumedaHironaka IgarashiRamil GabdulkhaevHaruhiko TakahashiKunio MotohashiRyosuke OguraJun WatanabeYoshihiro TsukamotoKouichirou OkamotoAkiyoshi KakitaTsutomu NakadaYukihiko FujiiMDPI AGarticle2-hydroxyglutarategliomamagnetic resonance spectroscopyrare IDH mutationsfalse-positiveMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2129, p 2129 (2021)
institution DOAJ
collection DOAJ
language EN
topic 2-hydroxyglutarate
glioma
magnetic resonance spectroscopy
rare IDH mutations
false-positive
Medicine (General)
R5-920
spellingShingle 2-hydroxyglutarate
glioma
magnetic resonance spectroscopy
rare IDH mutations
false-positive
Medicine (General)
R5-920
Manabu Natsumeda
Hironaka Igarashi
Ramil Gabdulkhaev
Haruhiko Takahashi
Kunio Motohashi
Ryosuke Ogura
Jun Watanabe
Yoshihiro Tsukamoto
Kouichirou Okamoto
Akiyoshi Kakita
Tsutomu Nakada
Yukihiko Fujii
Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
description We have previously published a study on the reliable detection of 2-hydroxyglutarate (2HG) in lower-grade gliomas by magnetic resonance spectroscopy (MRS). In this short article, we re-evaluated five glioma cases originally assessed as isocitrate dehydrogenase (IDH) wildtype, which showed a high accumulation of 2HG, and were thought to be false-positives. A new primer was used for the detection of <i>IDH2</i> mutation by Sanger sequencing. Adequate tissue for DNA analysis was available in 4 out of 5 cases. We found rare <i>IDH2</i> mutations in two cases, with <i>IDH2</i> R172W mutation in one case and <i>IDH2</i> R172K mutation in another case. Both cases had very small mutant peaks, suggesting that the tumor volume was low in the tumor samples. Thus, the specificity of MRS for detecting IDH1/2 mutations was higher (81.3%) than that originally reported (72.2%). The detection of 2HG by MRS can aid in the diagnosis of rare, non-IDH1-R132H <i>IDH1</i> and <i>IDH2</i> mutations in gliomas.
format article
author Manabu Natsumeda
Hironaka Igarashi
Ramil Gabdulkhaev
Haruhiko Takahashi
Kunio Motohashi
Ryosuke Ogura
Jun Watanabe
Yoshihiro Tsukamoto
Kouichirou Okamoto
Akiyoshi Kakita
Tsutomu Nakada
Yukihiko Fujii
author_facet Manabu Natsumeda
Hironaka Igarashi
Ramil Gabdulkhaev
Haruhiko Takahashi
Kunio Motohashi
Ryosuke Ogura
Jun Watanabe
Yoshihiro Tsukamoto
Kouichirou Okamoto
Akiyoshi Kakita
Tsutomu Nakada
Yukihiko Fujii
author_sort Manabu Natsumeda
title Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
title_short Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
title_full Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
title_fullStr Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
title_full_unstemmed Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
title_sort detection of 2-hydroxyglutarate by 3.0-tesla magnetic resonance spectroscopy in gliomas with rare idh mutations: making sense of “false-positive” cases
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/02c8ce6392cb47eda48b441c0572e5df
work_keys_str_mv AT manabunatsumeda detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT hironakaigarashi detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT ramilgabdulkhaev detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT haruhikotakahashi detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT kuniomotohashi detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT ryosukeogura detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT junwatanabe detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT yoshihirotsukamoto detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT kouichirouokamoto detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT akiyoshikakita detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT tsutomunakada detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
AT yukihikofujii detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases
_version_ 1718412449479131136